Microsoft: A Critical Point in Valuation Momentum
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
Ensysce Biosciences (ENSC) stock forecast for 2025
Updated: May 20, 2025 (23:02)
Sector: HealthcareThe share price of Ensysce Biosciences, Inc. (ENSC) now
50/200 Day Moving Average: $2.792 / $5.54
This figure corresponds to the Average Price over the previous 50/200 days. For Ensysce Biosciences stocks, the 50-day moving average is the resistance level today.
For Ensysce Biosciences stocks, the 200-day moving average is the resistance level today.
Are you interested in Ensysce Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Ensysce Biosciences stock price in 2025. How much will one Ensysce Biosciences share be worth in 2025? Is it worth taking profit / loss on ENSC stock now or waiting? What are analysts' forecasts for Ensysce Biosciences stock?
We forecast Ensysce Biosciences stock performance using neural networks based on historical data on ENSC stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Ensysce Biosciences, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Ensysce Biosciences analysts is $20.23. Today 200 Day Moving Average is the resistance level (5.54 $). 50 Day Moving Average is the resistance level (2.792 $).
Historical and forecast chart of Ensysce Biosciences, Inc. stock
The chart below shows the historical price of Ensysce Biosciences stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ENSC stock price can be found in the table below.
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on proprietary technology platforms to develop safer prescription drugs. The firm’s Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms, are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company is headquartered in La Jolla, CA.
Ensysce Biosciences (ENSC) Forecast for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun | 4.11 | 3.25 | 5.38 | 39.55 % |
| Jul | 3.78 | 2.56 | 5.53 | 53.76 % |
| Aug | 4.49 | 2.44 | 5.70 | 57.23 % |
| Sep | 4.88 | 3.84 | 5.56 | 31.03 % |
| Oct | 5.56 | 3.29 | 7.97 | 58.74 % |
| Nov | 5.60 | 3.21 | 6.79 | 52.78 % |
| Dec | 5.36 | 4.38 | 7.52 | 41.75 % |
Ensysce Biosciences information and performance
250 WEST 57TH ST., SUITE 2223, NEW YORK, NY, US
Market capitalization of the Ensysce Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ENSC shares in the company outstanding by the market price of one share.
EBITDA of Ensysce Biosciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Ensysce Biosciences price target for 2025 by month
Target values for the price of one Ensysce Biosciences share for Jun 2025.
In Jun, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 39.547% volatility is expected.
Pessimistic target level: 3.25
Optimistic target level: 5.38
Target values for the price of one Ensysce Biosciences share for Jul 2025.
In Jul, the Negative dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 53.765% volatility is expected.
Pessimistic target level: 2.56
Optimistic target level: 5.53
Target values for the price of one Ensysce Biosciences share for Aug 2025.
In Aug, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 57.229% volatility is expected.
Pessimistic target level: 2.44
Optimistic target level: 5.70
Target values for the price of one Ensysce Biosciences share for Sep 2025.
In Sep, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 31.027% volatility is expected.
Pessimistic target level: 3.84
Optimistic target level: 5.56
Target values for the price of one Ensysce Biosciences share for Oct 2025.
In Oct, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 58.740% volatility is expected.
Pessimistic target level: 3.29
Optimistic target level: 7.97
Target values for the price of one Ensysce Biosciences share for Nov 2025.
In Nov, the Positive dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 52.781% volatility is expected.
Pessimistic target level: 3.21
Optimistic target level: 6.79
Target values for the price of one Ensysce Biosciences share for Dec 2025.
In Dec, the Negative dynamics for Ensysce Biosciences, Inc. shares will prevail with possible monthly volatility of 41.751% volatility is expected.
Pessimistic target level: 4.38
Optimistic target level: 7.52
